Help
Posted Mon, Nov, 07,2011
The Editor in Chief of Clinical Medical Insights: Oncology, Dr William C S Cho, has awarded an endorsement to 'Management Options in Advanced Prostate Cancer: What is the Role for Sipuleucel-T?'
In the endorsement the Editor in Chief writes:
Therapeutic advances changed dramatically in 2010 with the U.S. FDA approval of the autologous cellular immunotherapy sipuleucel-T for the treatment of men with asymptomatic or minimally symptomatic metastatic CRPC. This is an updated review on the data regarding therapeutic options with particular focus on the emerging strategies for incorporating sipuleucel-T into this changing landscape.
To read more visit the article now: Management Options in Advanced Prostate Cancer: What is the Role for Sipuleucel-T
Posted in: Editor in Chief Endorsed Articles
News Categories
Thu 08 Oct, 2015
Published This Week (5th - 9th October)Thu 08 Oct, 2015
Biomarker Insights Paper Endorsed by Editor in ChiefWed 07 Oct, 2015
Interview with Professor Jamie DaviesThis is the first time I have published published an article in Clinical Medicine Insights Case Report. I was pleased to find that the publishing staff were helpful in guiding my submission and I was impressed by the prompt processing and speed of publication.
Facebook Google+ Twitter
Pinterest Tumblr YouTube